by
on
under
∞ Permalink

4 SC AG – Produktpipeline und klinische Studien

Posted on by

Herr Dr Jason Loveridge, CEO 4 SC AG, spricht über die Produktpipeline und klinische Studien.

    Die Fragen im Einzelnen:

  • 4SC is a biopharmaceutical company developing drugs that target cancer through epigenetic mechanisms – please explain in more detail.
  • What does 4SC’s product pipeline look like and which clinical studies do you conduct at current?
  • What is your vision for 2020?